Characterisation of suppressor cells generated following cryosurgery of an HSV-2-induced fibrosarcoma.
Cryosurgery of a primary HSV-2-induced hamster fibrosarcoma resulted in the generation of a population of suppressor cells. These cells were detectable in the spleen 1-10 days post-cryosurgery by their ability to suppress the proliferation of immunocompetent splenic T-lymphocytes following exposure to concanavalin A (Con A). The spleens of tumour-bearing (t.b.) animals which received cryosurgery 3 days previously displayed gross splenomegaly due to the generation of large numbers of highly proliferative erythroblasts. The erythroblast cells were unlikely to be the source of suppression since time course studies have demonstrated the presence of suppressor cells before and after their appearance in the spleen. The erythroblasts therefore probably reflected a response by the host to regenerate the erythrocytes lost during surgery and their presence was independent of the appearance of suppressor cells. Characterisation of the suppressor cell has revealed it to be non-adherent and esterase negative making it unlikely to be of macrophage (MO) lineage. This was confirmed by the ability of splenic MOs from day 3 t.b. cryosurgery-treated animals to completely restore Con A-dependent T-lymphocyte proliferation following MO depletion. As nylonwool column-eluted cells are able to suppress Con A-dependent T-lymphocyte proliferation, it seemed unlikely that B-lymphocytes play a role in cryosurgery-induced immunosuppression. These findings suggest that cryosurgery of a t.b. animal results in the generation of a population of T-lymphocytes capable of suppressing Con A-dependent T-lymphocyte proliferation, and infers that these cells contribute to the inferior prognosis following cryosurgery as compared to excision of a metastatic tumour.
Wing
M G
MG
University Surgical Unit, Northern General Hospital, Sheffield, U.K.
Rogers
K
K
Jacob
G
G
Rees
R C
RC
D000818:Animals; D000938:Antigen-Presenting Cells / Q000276:immunology; D043182:Carboxylesterase; D002265:Carboxylic Ester Hydrolases / Q000032:analysis; D002453:Cell Cycle; D002472:Cell Transformation, Viral; D006224:Cricetinae; D003452:Cryosurgery; D005354:Fibrosarcoma / Q000276:immunology / Q000473:pathology / Q000601:surgery*; D008213:Lymphocyte Activation / Q000187:drug effects; D008297:Male; D008647:Mesocricetus; D016685:Mitomycin; D008937:Mitomycins / Q000494:pharmacology; D011184:Postoperative Period; D012513:Sarcoma, Experimental / Q000276:immunology / Q000473:pathology / Q000601:surgery*; D018139:Simplexvirus / Q000502:physiology*; D013154:Spleen / Q000166:cytology; D050378:T-Lymphocytes, Regulatory / Q000187:drug effects / Q000201:enzymology / Q000276:immunology*
D008937:Mitomycins; D016685:Mitomycin; D002265:Carboxylic Ester Hydrolases; D043182:Carboxylesterase